Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Obesity - Body's effort to protect organs from lipids' toxic effects

The collection of symptoms that is the metabolic syndrome-insulin resistance, high cholesterol, fatty liver, and a greater risk for diabetes, heart disease, and stroke-are all related to obesity, but, according to a review in the March 9th issue of the Cell Press publication Trends in Endocrinology and Metabolism, not in the way you probably think they are.

9 Mar 2010

Researchers discuss possibility of using food to prevent individual's genes from expressing disease

Personal health recommendations and diets tailored to better prevent diseases may be in our future, just by focusing on genetics.

6 Mar 2010

PCRM: Nutrition professionals need to use Power Plate graphic as healthful alternative to USDA Food Pyramid

Fill your plate with fruits, vegetables, whole grains, and legumes each day to keep the doctor away, say doctors and dietitians with the Physicians Committee for Responsible Medicine. The nonprofit organization is running a full-page advertisement in March's Today's Dietitian urging nutrition professionals to use its new Power Plate graphic as a healthful alternative to the USDA Food Pyramid.

6 Mar 2010

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.

5 Mar 2010

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.

4 Mar 2010

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

A daily dose of vitamin D may just be what Chicagoans need to get through the long winter, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). This nutrient lifts mood during cold weather months when days are short and more time is spent indoors.

4 Mar 2010

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

CPEX Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. For the quarter CPEX reported revenues of $5.2 million and a net loss of $498,000. For the year CPEX reported revenues of $18.7 million and a net loss of $3.0 million.

3 Mar 2010

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced initial, positive results from a clinical trial evaluating 12 months of treatment with the EndoBarrier™ Gastrointestinal Liner.

3 Mar 2010

Common diabetes therapies may increase cancer risk, but more research needed

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

3 Mar 2010

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

The prevalence of overweight and obesity among Delaware children, ages 2-17, shows a flattening of the trajectory – no change- between 2006 and 2008. Because overweight and obesity rates had previously been climbing rapidly, the leveling-off is cause for optimism reports Nemours in the March 2010 edition of Health Affairs, a peer-reviewed publication and the country's most respected health policy journal.

3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Novo Nordisk awarded contract by VA as primary source provider of insulin

Novo Nordisk, a global healthcare company and leader in diabetes care, announced it has been awarded a contract by the U.S. Department of Veterans Affairs as the primary source provider of insulin. The one year contract began on March 1, 2010 and the VA has the option to renew the contract annually for up to an additional four years.

From Novo Nordisk 3 Mar 2010

Not getting enough sleep can cause fat to accumulate around organs, say researchers

Not getting enough sleep does more damage than just leaving you with puffy eyes. It can cause fat to accumulate around your organs - more dangerous, researchers say, than those pesky love handles and jiggly thighs.

2 Mar 2010

Daily consumption of chlorella can help maintain healthy body

Americans' dietary habits have been scrutinized for being dependent on processed, refined and incomplete foods. This has left many Americans to reassess the foods they eat and essentially reconstruct their personal food pyramids.

2 Mar 2010

Future work may uncover links between insulin use and cancer risk, say researchers

2 Mar 2010

Praxis to provide patient recruitment services for international type 2 diabetes study

Praxis, a company specializing in centralized patient recruitment for clinical research studies, will provide patient recruitment services to a top 20 pharmaceutical company for an international study on type 2 diabetes. The study explores an investigational drug’s effectiveness for maintaining glycemic control for individuals newly diagnosed with type 2 diabetes.

2 Mar 2010

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.

1 Mar 2010

Biodel seeks FDA marketing approval for VIAject

Biodel Inc. announced today that the U.S. Food and Drug Administration has accepted for review the company’s new drug application (NDA) seeking approval to market VIAject® for the treatment of diabetes. VIAject® is Biodel's proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs.

1 Mar 2010

Government has yet to confirm funding for ADI

With the sunset date for the Aboriginal Diabetes Initiative (ADI) rapidly approaching, the government has yet to confirm whether or not funding will continue after March 31st.

1 Mar 2010

Using genetic engineering techniques in pigs, scientists create new model of diabetes

The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.

1 Mar 2010

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Obesity - Body's effort to protect organs from lipids' toxic effects

Researchers discuss possibility of using food to prevent individual's genes from expressing disease

PCRM: Nutrition professionals need to use Power Plate graphic as healthful alternative to USDA Food Pyramid

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

Study suggests vitamin D supplements may decrease insulin resistance, fight depression

CPEX Pharmaceuticals' fourth-quarter 2009 revenues up 23%

Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announced

Common diabetes therapies may increase cancer risk, but more research needed

Nemours: New efforts to reduce prevalence of overweight and obesity among Delaware's children

Lotus Pharmaceuticals adds five new prescription drugs to its products

Novo Nordisk awarded contract by VA as primary source provider of insulin

Not getting enough sleep can cause fat to accumulate around organs, say researchers

Daily consumption of chlorella can help maintain healthy body

Future work may uncover links between insulin use and cancer risk, say researchers

Praxis to provide patient recruitment services for international type 2 diabetes study

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Biodel seeks FDA marketing approval for VIAject

Government has yet to confirm funding for ADI

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in